Peptide nucleic acids: versatile tools for gene therapy strategies.
Peptide nucleic acids, or PNAs, are oligonucleotide analogs in which the phosphodiester backbone is replaced with a polyamide structure. First synthesized less than 10 years ago, they have received great attention due to their several favorable properties, including resistance to nuclease and protease digestion, stability in serum and cell extracts, and their high affinity for RNA and single and double-stranded DNA targets. Although initially designed and demonstrated to function as antisense and antigene reagents that inhibit both transcription and translation by steric hindrance, more recent applications have included gene activation by synthetic promoter formation and mutagenesis of chromosomal targets. Most notably for gene delivery, they have been used to specifically label plasmids and act as adapters to link synthetic peptides or ligands to the DNA. Thus, their great potential lies in the ability to attach specific targeting peptides to plasmids to circumvent such barriers to gene transfer as cell-targeting or nuclear localization, thereby increasing the efficacy of gene therapy.
Dean
D A
DA
Department of Microbiology and Immunology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA. dean@northwestern.edu
D016375:Antisense Elements (Genetics) / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D004337:Drug Carriers; D016503:Drug Delivery Systems; D015870:Gene Expression / Q000187:drug effects*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D009153:Mutagens / Q000737:chemistry / Q000494:pharmacology; D020135:Peptide Nucleic Acids / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use
D016375:Antisense Elements (Genetics); D004337:Drug Carriers; D009153:Mutagens; D020135:Peptide Nucleic Acids